发明名称 |
Extracorporeal photopheresis in combination with anti-TNF treatment |
摘要 |
The treatment of an autoimmune disease, an atopic disease, transplantion rejection or GVHD or ameliorating one or more symptoms thereof involves the use of a combination therapy. The therapy involves administering to a subject an extracorporeal photopheresis and a TNF alpha antagonist. In particular, the extracorporeal photopheresis can comprise a psoralen (e.g. 8-MOP) and UVA, and the TNF alpha antagonist can be Infliximab, Adalimulab or Etanercept. |
申请公布号 |
EP1550454(A1) |
申请公布日期 |
2005.07.06 |
申请号 |
EP20040258069 |
申请日期 |
2004.12.22 |
申请人 |
THERAKOS, INC. |
发明人 |
GREGORY, DAVID;CAMPBEL, KIM;GILES-KOMAR, JILL;HARRIMAN, GREGORY |
分类号 |
A61K31/366;A61K31/37;A61K35/12;A61K35/14;A61K38/17;A61K38/19;A61K39/395;A61K41/00;A61K45/00;A61M1/36;A61N1/30;A61P1/04;A61P3/10;A61P5/14;A61P9/10;A61P25/00;A61P25/28;A61P29/00;A61P35/02;A61P37/06;C07K16/24;(IPC1-7):A61K38/19 |
主分类号 |
A61K31/366 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|